Infant Bacterial Therapeutics AB - Class B

STU:9IB (Sweden)   Class B
€ 8.76 (+1.15%) Aug 23
At Loss
P/B:
5.08
Market Cap:
€ 123.60M ($ 137.93M)
Enterprise V:
€ 96.42M ($ 107.60M)
Volume:
-
Avg Vol (2M):
228.00
Trade In:

Infant Bacterial Therapeutics AB Valuation Measures